WO1999026612A1 - Nouveaux modulateurs de recepteurs de cannabinoïdes - Google Patents

Nouveaux modulateurs de recepteurs de cannabinoïdes Download PDF

Info

Publication number
WO1999026612A1
WO1999026612A1 PCT/US1998/024803 US9824803W WO9926612A1 WO 1999026612 A1 WO1999026612 A1 WO 1999026612A1 US 9824803 W US9824803 W US 9824803W WO 9926612 A1 WO9926612 A1 WO 9926612A1
Authority
WO
WIPO (PCT)
Prior art keywords
receptor
pharmaceutically acceptable
subject
effective amount
phenol
Prior art date
Application number
PCT/US1998/024803
Other languages
English (en)
Inventor
Paul E. Bender
Siegfried Benjamin Christensen, Iv
Jonathan A. Lee
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of WO1999026612A1 publication Critical patent/WO1999026612A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols

Abstract

Cette invention se rapporte à des modulateurs de récepteurs de cannabinoïdes et à des procédés d'utilisation de ces modulateurs.
PCT/US1998/024803 1997-11-21 1998-11-20 Nouveaux modulateurs de recepteurs de cannabinoïdes WO1999026612A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6635397P 1997-11-21 1997-11-21
US60/066,353 1997-11-21
US6808597P 1997-12-19 1997-12-19
US60/068,085 1997-12-19

Publications (1)

Publication Number Publication Date
WO1999026612A1 true WO1999026612A1 (fr) 1999-06-03

Family

ID=26746664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/024803 WO1999026612A1 (fr) 1997-11-21 1998-11-20 Nouveaux modulateurs de recepteurs de cannabinoïdes

Country Status (1)

Country Link
WO (1) WO1999026612A1 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028588A1 (fr) * 1999-10-15 2001-04-26 Universite De Montreal Cannabinoides utilises en tant que vasodilatateurs et cardioprotecteurs contre l'ischemie
WO2004078261A1 (fr) * 2003-03-07 2004-09-16 The University Court Of The University Of Aberdeen Agonistes inverses de recepteurs de cannabinoides et antagonistes neutres agissant en tant qu'agents therapeutiques destines au traitement de troubles osseux
WO2004103410A1 (fr) * 2002-06-06 2004-12-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions de procedes et articles de fabrication destines a moduler la croissance osseuse
US7067539B2 (en) 2001-02-08 2006-06-27 Schering Corporation Cannabinoid receptor ligands
US7071213B2 (en) 2001-11-14 2006-07-04 Schering Corporation Cannabinoid receptor ligands
US7217732B2 (en) 2002-06-19 2007-05-15 Schering Corporation Cannabinoid receptor agonists
US7351729B2 (en) 2002-03-08 2008-04-01 Signal Pharmaceuticals, Llc JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
WO2008065939A1 (fr) * 2006-11-29 2008-06-05 Idemitsu Kosan Co., Ltd. Dérivé d'adamantane, son procédé de fabrication, et composition de résine contenant un dérivé d'adamantane
US7507767B2 (en) 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
US7642272B2 (en) 2003-03-20 2010-01-05 Schering Corporation Cannabinoid receptor ligands

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OONG S. H.: "ADAMANTYL-SUBSTITUTED PHENOLS.", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL COMMUNICATIONS., CHEMICAL SOCIETY. LETCHWORTH., GB, vol. 18., 1 January 1970 (1970-01-01), GB, pages 1180., XP002916566, ISSN: 0022-4936 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028588A1 (fr) * 1999-10-15 2001-04-26 Universite De Montreal Cannabinoides utilises en tant que vasodilatateurs et cardioprotecteurs contre l'ischemie
US7718702B2 (en) 2001-02-08 2010-05-18 Schering Corporation Cannabinoid receptor ligands
US7507767B2 (en) 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
US7067539B2 (en) 2001-02-08 2006-06-27 Schering Corporation Cannabinoid receptor ligands
US7071213B2 (en) 2001-11-14 2006-07-04 Schering Corporation Cannabinoid receptor ligands
US7645774B2 (en) 2001-11-14 2010-01-12 Schering Corporation Cannabinoid receptor ligands
US7351729B2 (en) 2002-03-08 2008-04-01 Signal Pharmaceuticals, Llc JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
WO2004103410A1 (fr) * 2002-06-06 2004-12-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions de procedes et articles de fabrication destines a moduler la croissance osseuse
US7749953B2 (en) 2002-06-06 2010-07-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods compositions and articles of manufacture for modulating bone growth
US7217732B2 (en) 2002-06-19 2007-05-15 Schering Corporation Cannabinoid receptor agonists
WO2004078261A1 (fr) * 2003-03-07 2004-09-16 The University Court Of The University Of Aberdeen Agonistes inverses de recepteurs de cannabinoides et antagonistes neutres agissant en tant qu'agents therapeutiques destines au traitement de troubles osseux
US7642272B2 (en) 2003-03-20 2010-01-05 Schering Corporation Cannabinoid receptor ligands
WO2008065939A1 (fr) * 2006-11-29 2008-06-05 Idemitsu Kosan Co., Ltd. Dérivé d'adamantane, son procédé de fabrication, et composition de résine contenant un dérivé d'adamantane
JP2008133246A (ja) * 2006-11-29 2008-06-12 Idemitsu Kosan Co Ltd アダマンタン誘導体、その製造方法及びアダマンタン誘導体を含む樹脂組成物
US8110614B2 (en) 2006-11-29 2012-02-07 Idemitsu Kosan Co., Ltd. Adamantane derivative, method for producing the same, and resin composition containing adamantane derivative
KR101440769B1 (ko) * 2006-11-29 2014-09-23 오사카 유키가가쿠고교 가부시키가이샤 아다만탄 유도체, 그 제조 방법 및 아다만탄 유도체를 함유하는 수지 조성물

Similar Documents

Publication Publication Date Title
JP7066768B2 (ja) 細胞内カルシウムを調節する化合物
US5948777A (en) Cannabinoid receptor agonists
JP5782377B2 (ja) 細胞内カルシウムを調節する化合物
EP1908753B1 (fr) Nouveau dérivé d'acétamide d'hétérocyclidène
JP2009538893A (ja) カンナビノイドの新規な使用
JP5526362B2 (ja) Ｎ−アシルエタノールアミン−加水分解酸性アミダーゼを阻害する組成物及び方法
JPWO2007020888A1 (ja) 脳・神経細胞保護剤および睡眠障害治療薬
CN101848910B (zh) 作为选择性11-β-羟基类固醇脱氢酶1型抑制剂的7-氮杂吲哚衍生物
CN101652359A (zh) 作为羟类固醇脱氢酶抑制剂的吲哚-和苯并咪唑酰胺类
CN103012378A (zh) 作为5-ht2a血清素受体调节剂适用于治疗与其相关的病症的3-苯基-吡唑衍生物
CN103554104A (zh) 用作jak和其它蛋白激酶抑制剂的氮杂吲哚
AU2012222146B2 (en) Crystalline forms and processes for the preparation of condensed azacycles ( cannabinoid receptor modulators)
JP2011516599A (ja) ニコチン性アセチルコリン受容体サブタイプα７のモジュレーターとしてのインドール類
CN103180316A (zh) 调节细胞内钙的化合物
TW200831089A (en) Substituted bicyclocarboxyamide compounds
JP2008156297A (ja) セロトニン２ｂおよび／または２ｃ受容体拮抗剤
CN101573332A (zh) 作为5-ht6抑制剂的芳基磺酰基吡咯烷类
WO1999026612A1 (fr) Nouveaux modulateurs de recepteurs de cannabinoïdes
WO2006118307A1 (fr) Agent therapeutique contre la douleur
JPH02270855A (ja) 抗炎症性アリール化合物
MXPA02011160A (es) Inhibidores del transporte de fosfato.
JP2007513872A (ja) Ｃｂ１拮抗作用を示す化合物の新規の医学的用途および前記化合物を伴う組み合わせ治療
JP2007262022A (ja) 新規２−チオフェンカルボキサミド誘導体
CA2621370A1 (fr) Sels salicylate et gentisate d'un compose piperazine
TW201032805A (en) Pharmaceutical compositions comprising a compound having suppressive effect on nutrient digestion or absorption and a cyclohexanecarboxamide derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase